Celltech regroups after Pfizer fallout
Tuesday 02 December 2003
Shares in Celltech jumped yesterday on hopes the biotech company could become a takeover target after it regained the rights to market its most advanced new drug.
Pfizer, the world's largest pharmaceutical group, signalled last month that it would drop the product, a treatment for rheumatoid arthritis codenamed CDP870, unless Celltech agreed to a dramatically lower share of the profits.
Celltech said yesterday that it had refused Pfizer's demands and the partnership would be dissolved by February. The UK group will now decide whether to re-license the drug immediately or to spend an estimated $100m (£58m) conducting the last of the human trials needed.
Celltech, which is believed to have attracted takeover interest from the Swiss biotech group Serono, promised a decision on CDP870's future early in the new year.
Goran Ando, Celltech's chief executive, said he would "start returning calls" from a number of biotech and pharmaceutical companies which had expressed an interest in bankrolling CDP870 since the dispute with Pfizer became public.
Shareholders might be better served by Celltech investing in the further rheumatoid arthritis trials itself, he said. "We generate £50m of cash a year, so we can handle all the permutations," Mr Ando said. Celltech shares rose 23.5p to 375p yesterday.
- 1 Unseen Charlie and the Chocolate Factory chapter deemed 'too subversive' released
- 3 Joan Rivers: 'Palestinians deserve to be dead'
- 4 A teacher speaks out: 'I'm effectively being forced out of a career that I wanted to love'
- 5 Mexican woman becomes world’s 'oldest person' at 127
Israel-Gaza crisis: YouTube footage shows scale of destruction after 50 days of shelling
iPhone 6 'hidden code' could indicate sharper screens or bigger phones
Keira Knightley topless: Conservative actress does own take on #Freethenipple campaign for Interview Magazine
Joan Rivers: 'Palestinians deserve to be dead'
Ebola virus: It's ripped through towns – now the deadliest ever outbreak of the virus is heading for Africa's teeming cities
Robin Williams Emmys tribute led by Billy Crystal criticised for including 'racist' joke about Muslim woman
Rotherham child sex abuse scandal: Labour Home Office to be probed over what Tony Blair's government knew - and when
The Rotherham child abuse scandal is a tale of apologists, misogyny and double standards
What do immigrants really think of Britain? Polish immigrant's Reddit post goes viral
Do you realise just how foolish the UK looks?
With Douglas Carswell joining Ukip, my party has taken another giant step forward
iJobs Money & Business
£40000 - £45000 per annum: Ashdown Group: An established professional services...
£18000 - £23000 per annum + Commission: SThree: Real Staffing are currently lo...
£28 - 32k + Uncapped Commission: Guru Careers: A Business Development Manager ...
£40000 - £70000 per annum + Bonus+Benefits+Package: Harrington Starr: C# .NET ...